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ABSTRACT 
The purpose of this study is to prepare a bilayer tablet of Propranolol HCl using Wet granulation technology and to formulate 
optimized formulation. Propranolol HCl, a nonselective β-adrenergic blocker which is the best drug candidate to formulate in to 
bilayer tablets fast release of drug from immediate release layer can give rapid onset of action which will help which will help to 
reduce Blood pressure within short period of time while maintenance dose of Propranolol HCl will maintain plasma concentration 
within therapeutic range for 12hrs  having short half-life (3-5 hr) and first pass metabolism favors for sustained release dosage form. 
The tablets were prepared by wet granulation method. Hydrophobic matrix materials such as ethyl cellulose were used, which can 
release the drug up to 12 hrs in predetermined rate. Binder used was Starch paste (10%).The influence of hydrophobic polymer and 
granulation technique was studied. In this study, a bilayer tablet was prepared which contains an immediate release portion layer and 
sustained release portion.  Ethyl cellulose were used as in alone, for Sustained release and Superdisintegrant Cross Povidone for 
immediate release used. The bilayer tablets were characterized by Calibration Curve, Calculation of Dose, Bulk Density, Tapped 
density, Angle of repose, Carr’s Index, Hausner’s ratio, Weight Variation, Hardness, Friability, Thickness, Drug Content and In-
vitro dissolution profile. The granules showed satisfactory flow properties and compressibility. Best Formulation F3 [Drug + 
Ethylcellulose (1:3)] showed High % drug release 87.40% release, high drug content, high hardness and friability. Hence, it was 
found better than F1 and F2 so F3 is the best formulation. 
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1. INTRODUCTION: 
Oral route is one of the most popular routes of drug 
delivery due to its ease of administration, patient 
compliance, least sterility constraints and flexible design 
of Dosage form. The oral route of administration is the 
most preferred route due to its many advantages like 
ease of administration, accurate dosage, self-medication, 
pain avoidance, versatility and patient compliance. 
Tablets and capsules are the most popular dosage forms. 
Ideally a drug to provide desired therapeutic action 
should arrive rapidly at the site of action in optimum 
concentration, remain there for the desire time, be 
excluded from other site. The fact that absorption rate of 
drug into the body can be decreased by reduction of the 
rate of release of the drug from the dosage form is one of 
the most recent and interesting result of pharmaceutical 
research. But one important drawback of such dosage 
forms is Dysphasia or difficulty in swallowing
1-2
. This is 
seen to afflict nearly 35% of the general population. This 
disorder is also associated with a number of pathological 
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conditions including stroke, Parkinson’s disease, 
neurological disorders, AIDS etc. 
           Dual release Tablets is a unit compressed Tablets 
dosage form intended for oral Application. It contains 
two layers in which one layer having conventional or 
immediate release part of single or multiple actives; 
another layer is sustained or controlled release part of 
single or multiple actives. They are also called as 
Bilayer Tablets, multi-layer Matrix Tablets.. A bilayer 
Tablets is a type of multiple compressed Tablets. Tablets 
are composed of two layers of granulation compressed 
together. Monograms and other distinctive marking may 
be compressed in the surface of the bilayer Tablets. 
Coloring the separate layer provide many possibilities 
for unique Tablets identity. There are some applications 
like Bilayer Tablets are mainly used in the combination 
therapy. Bilayer Tablets are used to deliver the loading 
dose and sustained dose of the same or different drugs. 
Bilayer Tablets are used to deliver the two different 
drugs having different release. They are used as an 
extension of a conventional technology Potential use of 
single entity feed granules. Patient compliance is 
enhanced leading to improved drug regimen efficacy. 
Patient convenience is improved because fewer daily 
doses are required compared to traditional drug delivery 
system. Maintain physical and chemical stability. Retain 
potency and ensure dose accuracy
3-4
. 
1.1 Advantages of Bilayer Tablets over Conventional 
Tablets:        
Blood level of a drug can be held at consistent 
therapeutic levels for improved drug delivery, accuracy, 
safety and reduced side effects. Reduction of adverse 
effects can be accomplished by targeting the drug 
release to the absorption site as well as controlling the 
rate of release, enabling the total drug content to be 
reduced. Patient convenience is improved because fewer 
daily doses are required compared to traditional delivery 
systems. Patient compliance is enhanced leading to 
improved drug regimen efficacy. Bilayer Tablets readily 
lend themselves to repeat action products, where in one 
layer on layered Tablets provides the initial dose, rapidly 
disintegrate in the stomach. The other layers are 
insoluble in gastric media but are released in the 
intestinal environment. In bilayer Tablets, where in one 
layer on layered Tablets provides as immediate Release 
and other layer acts as sustained release. In sustained 
release drug delivery system, several approaches are 
available to add the loading dose to the maintenance 
dose such as simple addition of a sustained dose of drug 
to the sustained portion and placement of initial dose in 
a Tablets coat with the sustaining portion in the core as 
in compression coated Tablets. An alternative approach 
for having the loading dose and maintenance dose in a 
Tablets is the formulation of drug in a multi layered 
Tablets or bilayer Tablets system. This bilayer approach 
is a convenient method. Hence it makes possible to 
formulate sustained release preparations with the 
immediate release quantity in one layer and the slow 
release portion will disintegrate rapidly after ingestion 
thus providing the Initial dose of medication for 
immediate onset of action, where as the another layer in 
the matrix layer remain intact during most of the time of 
its passage through the intestine, While dissolving 
slowly (sustained manner) from its exposed faces in this 
passage, which helps to maintain the blood level initially 
reached
5
. 
1.2 Ideal Characteristics of Bilayer Tablets
6
:- 
1) A bi-layer tablet should have elegant product 
identity while free of defects like chips, cracks, 
discoloration and contamination. 
2) It should have sufficient strength to with stand 
mechanical shock during its production packaging, 
shipping and dispensing. 
3) It should have the chemical and physical stability to 
maintain its physical attributes over time. The bi-
layer Tablets must be able to release the medicinal 
agents in a predictable and reproducible manner. 
4) It must have a chemical stability shelf-life, so as not 
to follow alteration of the medicinal agents. 
1.3 Challenges in Bilayer Tablet Manufacturing
7
: 
Conceptually, bilayer Tablets can be seen as two single-
layer Tablets compressed into one. In Practice, there are 
some manufacturing challenges. 
1.3.1 Delamination:  
Tablets fall apart when the two halves of the Tablets do 
not bond completely. The two granulations should 
adhere when compressed. 
1.3.2 Cross-contamination:  
When the granulation of the first layer intermingles with 
the granulation of the second layer or vice versa, cross-
contamination occurs. It may conquer the very purpose 
of the bilayer Tablets. Proper dust collection goes a long 
way toward preventing cross contamination. 
1.3.3 Production yields: 
To prevent cross contamination, dust collection is 
required which leads to losses. Thus, bilayer Tablets 
have lower yields than single-layer Tablets. 
1.3.4 Cost:  
Bilayer tableting is more expensive than single layer 
tableting for several reasons. First, the Tablets   press 
costs more. Second, the press generally runs more 
slowly in bilayer mode. Third, development of two 
compatible granulations is must, which means more time 
spent on formulation development, analysis and 
validation. These factors, if not well 
controlled/optimized, in one way or another will impact 
the bilayer compression per se and the quality attributes 
of the bilayer Tablets (sufficient mechanical strength to 
maintain its integrity and individual layer weight 
control). Therefore, it is critical to obtain an insight into 
the root causes to enable design of a robust product and 
process. 
1.4 Types of bilayer Tablets press: 
1.4.1 Single sided press:  
The simplest design is a single sided press with both 
chambers of the doublet feeder separated from each 
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other. Each chamber is gravity or forced fed with 
different power, producing the two individual layers of 
Tablets. When die passes under the feeder, it is first 
loaded with the first layer powder followed by the 
second layer powder. Then the entire Tablets is 
compressed in one or two steps. 
Limitations of the single sided press:  
1) No weight monitoring / control of the individual 
layers. 
2) No distinct visual separation between the two 
layers. 
3) Very short first layer dwell time due to the small 
compression roller, possibly resulting in poor 
deaceration, capping and hardness problems. 
4) This may be corrected by reducing the turret 
rotation speed (to extend the dwell time) but with 
the consequence of lower Tablets output. 
1.4.2 Double sided Tablets press:  
In most double sided Tablets presses with automated 
production control use compression force to monitor and 
control Tablets weight. The effective peak compression 
force exerted on each individual Tablets or layer is 
measured by the control system at main compression of 
the layer. This measured peak compression force is the 
signal used by the control system to reject out of 
tolerance and correct the die fill depth when required.  
1.4.3 Bilayer Tablets press with displacement 
monitoring: 
The displacement Tablets weight control principle is 
fundamentally different from the principle based upon 
compression force. When measuring displacement, the 
control system sensitivity does not depend on the 
Tablets weight but depends on the applied 
precompression force. 
1.5 Preparation of Bilayer Tablets:
9-11
 
Bilayer Tablets are prepared with one layer of drug for 
immediate release with the second layer designed to 
release drug later, either as a second dose or in an 
extended release. The bilayer Tablets with two 
incompatible drugs can also be prepared by compressing 
separate layers of each drug so as to minimize area of 
contact between two layers. An additional intermediate 
layer of inert material may also be included. To produce 
adequate Tablets formulation, certain requirements such 
as sufficient mechanical strength and desired drug 
release profile must be met. At times, this may be 
difficult task for formulator to achieve these conditions 
especially in bilayer Tablets formulation where double 
compression technique is involved, because of poor flow 
and compatibility characteristic of the drug which will 
result in capping and/or lamination. The compaction of a 
material involves both the compressibility and 
consolidation. 
Compression: 
It is defined as reduction in bulk volume by eliminating 
voids and bringing particles into closer contacts. 
Consolidation: 
 It is the property of the material in which there is 
increased mechanical strength due to interparticulate 
interaction (bonding). The compression force on layer 1 
was found to be major factor influencing Tablets 
delamination. 
2. MATERIAL AND METHOD: 
Materials: 
Propranolol Hydrochloride was obtained as a gift sample 
from Renuka Raw Pharma (Mumbai), India. All over 
chemicals were purchased from Merck Research Lab., 
Fine Chem Industries, Mumbai, India. 
Methods: 
2.1 Preformulation Studies: 
The drug substance of Propranolol HCl was 
characterized for their identity and purity. The following 
studies were performed
12
: 
2.2 Determination of Absorption Maxima of 
Propranolol HCl:  
A solution of Propranolol HCl containing the 
concentration 10 μg/ ml was prepared in 0.1N HCl, & 
phosphate buffer 6.8P
H
 respectively, UV spectrum was 
taken using Double beam UV/VIS spectrophotometer. 
The solution was scanned in the range of 200 – 400nm. 
2.3 Preparation Calibration Curve for Propranolol 
HCl:  
10mg of Propranolol HCl drug was accurately weighed 
and dissolved in 10ml of 0.1N HCl and 6.8 pH in 10 ml 
volumetric flask to make (1000 μg/ml) standard stock 
solution(1). Then 1 ml stock solution (1) was taken in 
another 10 ml volumetric flask to make (100 μg/ml) 
standard stock solution(2), then again 1 ml of stock 
solution (2) was taken in another 10 ml volumetric flask 
and then final concentrations were prepared 2, 4, 6, 8, 
and 10μg/ml with 0.1N HCL, and 6.8 pH. The 
absorbance of standard solution was determined using 
UV/ VIS spectrophotometer at 290nm. Linearity of 
standard curve was assessed from the square of 
correlation coefficient (r
2
) which is determined by least-
square linear regression analysis. 
2.4 Drug and Excipient Compatibility Studies: 
Compatibility of the Propranolol Hydrochloride with 
Ethylcellulose used to formulate bilayer tablets was 
established by FTIR spectral analysis. FTIR spectral 
analysis of Propranolol Hydrochloride, individual 
excipient and combination of Propranolol Hydrochloride 
and Ethylcellulose was carried out to investigate the 
changes in chemical composition of the drug after 
combining it with the excipients. Compatibility study 
was carried out on Fourier Transform Infrared 
Spectrometer
13
. 
2.5 Calculation of Dose:- 
The Loading dose and maintenance dose of Propranolol 
Bilayer tablets was calculated by following equation 
using available pharmacokinetic data. 
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 Dt = Dose ( 1+0.693 x t/t1/2) 
Where, Dt = Total dose of drug; Dose = dose of 
immediate release part (25mg); t= time (hours); t1/2 = 
half-life of drug (3.79) 
Dt = 25 ( 1+ 0.693 x 12/3.79) = 80 mg hence 
formulation should contain total dose 80mg with 25mg 
loading dose i.e. dose of immediate release and 55mg is 
maintenance dose i.e dose of sustained release. 
2.6 Manufacturing Process
14-18
:  
The bilayer Tablets of propranolol hydrochloride were 
prepared by the wet granulation method. The drug and 
polymers for both fast release and sustaining layer were 
passed through a 22-μm sieve before their use in the 
formulation.                       
2.6.1 Steps Involved in Formulation of Propranolol 
HCl Bilayer Tablets: 
Starch paste (10%m/m) as binder is used as granulating 
agent and granules are prepared. The  (Sustained release 
layer) Propranolol hydrochloride,  Ethyl cellulose, 
Magnesium stearate, Talc are passed through sieve 
No.60 and then Starch Paste added little by little so that 
a coherent mass formed when crumps on slight 
application of pressure then coherent mass passed 
through sieve No. 10. The granules dried at 60
0
C for 30 
minutes. All dried granules passed through sieve No. 22 
below which Sieve No. 44 was kept. The granules 
retained on sieve No. 44 were desired and the powder 
which passed through sieve No. 44 was fine granules. 
 
Table 1: Composition of Sustained Release Propranolol HCl Tablets 
Ingredients (mg) F1(1:1) F2 (1:2) F3 (1:3) 
Propranolol HCl 55 55 55 
Ethyl Cellulose 55 110 165 
Lactose 130 75 20 
Starch Paste 25 25 25 
Magnesium Stearate 3 3 3 
Talc 2 2 2 
Avg. Weight of SR  Layer Tablet 270 270 270 
 
 
2.6.2 Preparation of Immediate Release Propranolol 
HCl Tablet by Wet Granulation Method:  
Starch paste (10%m/m) as binder is used as granulating 
agent and granules are prepared. The  (Immediate 
release layer) Propranolol hydrochloride,  Cross 
Povidone, Magnesium stearate, Talc are passed through 
sieve No.60 and then Starch Paste added little by little so 
that a coherent mass formed when crumps on slight 
application of pressure then coherent mass passed 
through sieve No. 10. The granules dried at 60
0
C for 30 
minutes. All dried granules passed through sieve No. 22 
below which Sieve No. 44 was kept. The granules 
retained on sieve No. 44 were desired and the powder 
which passed through sieve No. 44 was fine granules. 
 
Table 2: Composition of Immediate Propranolol HCl Release Tablets 
Sr. No. Ingredients (mg) IR 
1 Propranolol HCl 25 
2 Cross Povidone 1 
3 Starch Paste (10%) 3 
4 Magnesium Stearate 0.5 
5 Talc 0.5 
 Avg. Weight of IR Layer Tablet 30 
 
Table 3: Total Weight of Propranolol HCl Bi-layer Tablets 
Total Weight of Bi-layer 
Tablets (mg) 
F1 (1:1) F2 (1:2) F3 (1:3) 
300 300 300 
 
2.7 Evaluation of Propranolol HCl Bilayer Tablets: 
2.7.1 Precompression Studies:  
The flow properties of immediate release blend and  
floating sustained release granules (before compression) 
were characterized in  terms of loose bulk density, 
Tapped bulk density, Angle of repose, Carr’s index   & 
Hausner’s ratio.                
a) Loose Bulk Density:  
It is indicative of the packing of particles and as such is 
greatly influenced by the size of granules. Loose bulk 
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density of Tablets was determined by pouring gently 2g 
of the powder blend from each formula through a glass 
funnel into 10ml measuring cylinder. The volumes 
occupied by the samples were noted. Loose bulk density 
was expressed in (g/ml) and calculated by using 
following formula.               
Bulk Density = (Weight of the Granule / Bulk volume) 
b) Tapped Bulk Density: 
It was determined by pouring gently 2 g of the powder 
blend from each formula through a glass funnel into 10 
ml measuring cylinder. The cylinder was tapped gently 
on to a hard surface from the height of 2 inches at 
second interval until a constant volume was obtained. 
Volume occupied by the sample after tapping was noted. 
Tapped density was expressed in (g/ml) and calculated 
by using following formula. 
Tapped Density = (Weight of the Granule / Tapped volume) 
c) Angle of Repose  
Angle of repose is defined as the maximum angle 
possible between the surface of the pile of the Granule 
and the horizontal plane. Angle of repose of different 
formulations was measured according to fixed height 
funnel standing method.  
tan θ = h / r ;      θ = tan -1  h / r) , 
d) Carr’s Index 
Compressibility index (CI) or Carr’s index value of 
microparticles was computed according to the equation:  
Carr (%) = [(Tapped density – Bulk Density) / Tapped 
Density] × 100 
e) Hausner’s Ratio: 
Hausner’s ratio of micro particles was determined by 
comparing the tapped density to the bulk density   using 
the equation:  
2.7.2 Postcompression Studies: 
a) Weight Variation: 
It was performed as per the method given in the Indian 
Pharmacopoeia (1996). 20 Tablets were selected 
randomly from the formulation and the average weight 
was determined. Then individual Tablets were weighed 
and the individual weight was compared with the 
average weight. Following are the formulas:  
%Deviation= (Average Weight – Individual Weight) / 
Average Weight.  x 100 
b) Hardness:  
This test is used to check the hardness of a tablet which 
may undergo chipping or breakage during storage, 
transportation and handling. In this five Tablets were 
selected at random and the hardness of each Tablets 
formulation and marketed Tablets was measured with 
Monsanto hardness tester. The hardness is usually 
measured in terms of kg/cm
2
.  
c) Friability:  
The friability test was carried out to evaluate the 
hardness and stability instantly. The Tablets friability 
was measured according to the Indian Pharmacopoeia. 
In this, 10 Tablets were weighed initially and put in a 
rotating apparatus drum (Roche friabilator). Then, they 
are subjected to fall from 6 inches height. After 
completion of 100 rotations, loose dust particles were 
removed from the Tablets after the test and the Tablets 
were again weighed. The Tablets friability was 
expressed in (%). The percentage friability of the Tablets 
formulation was calculated by using following formula 
is given below:  
%Friability=   Initial Wt of Tablets – Final Wt of Tablets x 100 
               Initial Wt of Tablets 
d) Tablets Thickness and Size:  
Thickness and size of Tablets were important for 
uniformity of Tablets size. Thickness and size of the 
Tablets formulation was measured using Vernier caliper 
and is expressed as (mm). 
e) Drug Content Uniformity:  
Ten Tablets were finely powdered and an amount 
equivalent to 40 mg of propranolol hydrochloride was 
accurately weighed and transferred to a 100 ml 
volumetric flask. Then 70ml methanol was added. The 
flask was shaken for 10 minutes. Finally, the volume 
was made up to the mark with methanol. The mixture 
was then filtered and 1 ml of the filtrate was suitably 
diluted with methanol to obtain a solution containing 
about 40μg ml-1 of propranolol hydrochloride and 
analyzed for Propranolol hydrochloride content at 290 
nm using a double beam UV/Visible and methanol as a 
blank. 
f) In-vitro Drug Release Study of Propranolol HCl 
Bilayer Tablets:  
Release of Propranolol Hydrochloride was determined 
using a USP, six stage dissolution rate test apparatus- I 
at 50rpm. The dissolution was studied using 900mL of 
simulated gastric fluid 0.1N HCl (without enzyme, pH 
1.2) for the first 2hrs and followed by a simulated 
intestinal fluid (without enzyme pH 6.8) for remaining 
10 hours. The temperature was maintained at 37±0.5
0
C. 
The sample (5ml) was withdrawn at different time 
intervals i.e.1,2,3,4,5,6,7,8,9,10,11,12 hrs filter through 
whatman filter paper and replaced by an equal volume of 
dissolution medium sample were suitably diluted and 
analyzed for Propranolol hydrochloride content at 
290nm. 
3. RESULTS AND DISCUSSION: 
3.1 Determination of Absorption Maxima of 
Propranolol HCl:  
The absorbance maximum of Propranolol HCl was 
found to be at 290 nm.  
3.2 Drug and Excipient Compatibility Studies: 
No significant changes were observed in the IR spectra 
as shown in Figure No. 2. 
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Figure 1: FTIR Spectra of Propranolol HCl 
 
Figure 2: FTIR Spectra of Propranolol HCl with 
Ethylcellulose 
 
 3.3 Pre Compression Parameters for Immediate Release Powder Blend: 
 The immediate release powder blend shows good flowing property. 
Table 4: Flow Property of Immediate Release Powder Blend 
Sr. No Parameters IR Formulation 
1 Bulk Density 0.551 
2 Tapped Density 0.760 
3 % Carr’s Index 27.52 
4 Hausner’s Ratio 1.13 
5 Angle of repose 24.89º 
 
3.4 Precompression Parameters of Sustained Release Granules of Propranolol HCl:  
The results for precompression parameters of sustained release granules of Propranolol HCl are shown in Table 5. 
Table 5: Precompression Parameters of Sustained Release Granules Propranolol HCl 
Sr. No Parameters F1 F2 F3 
1 Bulk Density (gm/ml) 0.6060 0.5882 0.5714 
2 Tapped Density 0.6451 0.6250 0.6060 
3 % Carr’s Index (%) 6.06 5.88 5.71 
4 Hausner’s Ratio 1.064 1.062 1.060 
5 Angle of repose 19.02
0
 22.61
0
 25.46
0
 
All the batches pass the Pharmacopoeial limits. 
3.5 Post Compression Parameters for Sustained Release Propranolol HCl Bilayer Tablets: 
The results for postcompression parameters of sustained release Propranolol HCl bilayer tablets are shown in Table 6. 
Table 6: Postcompression Parameters of Sustained Release Propranolol HCl Bilayer Tablet 
Sr. No Parameters F1 F2 F3 
1 Weight Variation 298 299 299 
2 Hardness (kg/cm
2
) 5.07 5.15 5.20 
3 % Friability (%) 0.33 0.67 1.00 
4 Thickness(mm) 4 4 4 
 
3.5.1 Determination of Drug Content:  
The results for drug content determination are predicted in Table 7. 
Table 7: Determination of Drug Content 
Formulation 
code 
Polymer /drug 
ratio 
Theoretical drug 
content(mg) 
Actual drug 
content (mg) 
Percentage 
yield 
F1 1:1 80 71.80 89.55 
F2 1:2 80 74.31 92.88 
F3 1:3 80 77.04 96.3 
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3.5.2 In-vitro Drug Release Study of Sustained Release Propranolol HCl Bilayer Tablets:  
Data for in-vitro drug release study is shown in Table 8. 
Table 8: Percentage Drug Release of Propranolol HCl Bilayer Tablet 
Time (hr) F1 F2 F3 
1 18.54545 19.90909 20.72727 
2 20.31818 21.40909 25.09091 
3 22.22727 25.77273 30.40909 
4 27.13636 30.81818 33.95455 
5 31.77273 36.68182 38.45455 
6 36.13636 40.22727 45.13636 
7 40.5 46.22727 55.77273 
8 44.72727 50.18182 59.04545 
9 50.45455 58.09091 65.04545 
10 56.04545 63.68182 72.81818 
11 65.45455 70.5 80.04545 
12 69.54545 76.77273 87.40909 
 
 
Figure 3: In vitro Drug Release Study of Propranolol 
HCl Bilayer Tablets 
4. CONCLUSION: 
In the present study, an attempt was made to prepare and 
evaluate bilayered matrix tablets by using synthetic 
Polymer. The Bi-layer tablets were prepared by wet 
granulation method. The research was undertaken with 
the aim to formulate and evaluate the bilayer tablets of 
Propranolol HCl using Ethylcellulose as polymers. The 
FTIR analysis ruled out the interaction between drug 
and polymers used in the preparation.  From results 
obtained, it was concluded that the formulation of 
bilayer tablet of Propranolol HCl containing 
Ethylcellulose (F3) as polymer was taken as ideal or 
optimized formulation for 12 hrs high release of drug 
i.e.87.40%, high drug content i.e. 96.3% and high 
hardness as it fulfils all the requirement of sustained 
release dosage form. 
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